Myrexis (MYRX)
News
| May 25 | Depressed From Recent News, Myrexis' Presentation At ASCO Draws Speculation |
| May 21 | 2 Pharmaceutical Companies Trading Below Net Cash |
| May 20 | Insider Buying Trends: Are These Cash-Rich Companies Ready For A Rally? |
| May 17 | $MYRX Insider Buy: $100K of stock bought by Belle Gerald P. between May 15, 2012 - May 16, 2012 http://stks.co/3sqN by MarketBrief |
| May 17 | MYREXIS, INC. Financials |
| May 15 | Yes, ETFs Sometimes Monkey With Stock Prices Barrons.com |
| May 14 | Myrexis Undervalued As BioPharma Transforms |
| May 11 | MYREXIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulati... |
| May 11 | Myrexis Appoints New Executive Management Team in Alignment With Strategic Initiative... |
| May 10 | Myrexis, Inc. (MYRX) Narrows Q1 Loss to 40c/Share Street Insider |
| Feb 27 | long $MYRX $3.32 by ivan_bg |
| Feb 15 | $MYRX Suspends All Preclinical And Clinical Programs by Benzinga |
| Feb 15 | $MYRX Exploring Strategic Alternatives by Benzinga |
| Feb 15 | $MYRX Halted on News by Benzinga |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Drugs - Generic
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Myrexis is down 40.72% over the last year vs S&P 500 Total Return up 2.32%, Salix Pharmaceuticals up 33.03%, and Watson Pharmaceuticals up 13.25%.
- MYRX Total Returns
- ^SPXTR Total Returns
- SLXP Total Returns
- WPI Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these MYRX related companies
Pro Strategies Featuring MYRX
Did Myrexis make it into our Pro Portfolio Strategies?
MYRX Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other MYRX Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MYRX | 2.45 | -0.07 | -2.78% | 66.48M |
| MYN | 14.42 | +0.01 | +0.07% | |
| MYM | 14.28 | +0.02 | +0.14% | |
| MYL | 21.53 | -0.36 | -1.64% | 9.345B |
| MYJ | 16.13 | -0.14 | -0.86% | |
| MYGN | 24.98 | -0.22 | -0.87% | 2.124B |
| MYF | 15.96 | -0.14 | -0.87% | |
| MYC | 16.30 | +0.01 | +0.06% | |
| MY | 1.38 | -0.14 | -9.21% | 190.00M |
| MXWL | 6.46 | -0.60 | -8.50% | 199.16M |
